Medical test performance / clinical statistics · BEGINNER LESSON
Specificity
Specificity is the proportion of people without the target disease who are correctly classified as negative by a test. It measures how well a test avoids false alarms in a defined population. [0]
What specificity is
In medicine, specificity describes how well a test identifies people who do not have the target disease. A highly specific test gives few false positive results, meaning few people without the disease are incorrectly labeled as having it. This idea is defined for a particular test in a particular population, so the number can change when the patient group changes. [0]
[1] The specificity trap in routine tumor biomarker interpretation
How it is used
Specificity is one way to describe test performance, along with sensitivity, positive predictive value (PPV), and negative predictive value (NPV). Sensitivity is the fraction of people with the disease who test positive. PPV is the chance that disease is present after a positive result. NPV is the chance that disease is absent after a negative result. The source warns that specificity does not by itself answer the clinical question of how likely cancer is in one patient after a result. [0]
[1] The specificity trap in routine tumor biomarker interpretation
Why biomarkers can be tricky
The source explains that some routine tumor biomarkers can rise for reasons other than cancer, such as inflammation, tissue injury, infection, liver or muscle injury, iron overload, or kidney problems. Because of this, a marker can be linked to cancer in one setting but still perform poorly as a stand-alone test for whether cancer is present. The best interpretation depends on the suspected tumor, disease stage, the patient’s baseline, and the marker’s change over time. [0]
[1] The specificity trap in routine tumor biomarker interpretation
Limits of specificity
Specificity is measured in a defined population and does not replace histopathology, imaging, or other validated decision pathways. For routine tumor-marker interpretation, the source says markers should be treated as conditional, trajectory-dependent signals rather than as final proof for or against cancer. In other words, specificity helps describe test quality, but it does not make a biomarker decisive on its own. [0]
[1] The specificity trap in routine tumor biomarker interpretation
SEE THE IDEA
How specificity fits into test interpretation
A biomarker or other test gives positive or negative results.
Specificity asks how many of these are correctly called negative.
These lower specificity because they are positive results in people without the disease.
Baseline, disease stage, and other illnesses affect how the result should be read.
Test results are judged against disease status in a defined population, then interpreted with clinical context.
Specificity describes one part of test performance, not the full meaning of a patient’s result. [0]
TRY IT YOURSELF
Test your understanding
Choose an answer, then check the explanation.
PUT IT TOGETHER
Match each concept to its meaning
Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.
4 pairs to match
Sources and further reading
This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.